Introduction {#s1}
============

During the early postnatal period, cardiomyocytes (CMs) undergo a switch from a proliferative, hyperplastic mode to non-proliferative, hypertrophic growth that persists throughout life ([@bib27]; [@bib44]; [@bib43]). This process is accompanied by multiple, highly synchronized cellular changes. The expression of cell-cycle and embryonic markers falls precipitously in CMs ([@bib48]), while the expression of CM differentiation genes increases, along with the appearance of sarcomeres, contractile units that undergo cross-striation to form a functional myoskeletal system within CMs. Further, mechanical and electrical cell-to-cell communication between CMs is established via intercalated discs, containing gap junctions, adherens junctions and desmosomes ([@bib33]; [@bib39]). In parallel, up-regulation of extracellular matrix (ECM) components, as well as increased cross-linking of matrix proteins, also occurs postnatally, leading to an overall stiffening of the heart tissue ([@bib20]; [@bib45]; [@bib30]). The mechanisms whereby these complex developmental processes are regulated and coordinated, and their putative effects on CM maturation, are yet enigmatic.

Over the first week of postnatal life in mice, most CMs exit the cell cycle and differentiate ([@bib44]), although some CMs undergo an additional burst of proliferation in the pre-adolescent period, driven by the thyroid hormone ([@bib31]). Mammalian CMs display distinct cycling phases: a fetal/neonatal phase in which nuclear division (karyokinesis) is immediately followed by cell division (cytokinesis), and a later neonatal phase, in which karyokinesis proceeds without cytokinesis, leading to binucleation ([@bib44]; [@bib26], [@bib28]; [@bib49]). Binucleation, hypertrophic growth, increased myofibrillar organization, and cell cycle withdrawal are all manifestations of the differentiated state of adult CMs ([@bib2]; [@bib32]; [@bib49]), while the 'terminal differentiation' state is yet uncertain.

Naturally, there are physiological advantages in the postnatal maturation of CMs. Nonetheless, loss of the proliferative potential of differentiated CMs creates a major barrier to cardiac regeneration after injury. In humans, myocardial infarction (MI) is a life-threatening disease leading to permanent loss of hundreds of millions of CMs, followed by an inflammatory response and formation of scar tissue, that progressively lead to cardiac dysfunction and heart failure ([@bib46]; [@bib3]).

Cardiac regeneration does exist in lower vertebrates such as newts and fish. The zebrafish heart, for example, is able to fully regenerate after injury, without scarring ([@bib37]). The lack of regenerative potential of the mammalian heart was challenged by Porrello and colleagues ([@bib35]), who showed that the neonatal murine heart displays a transient regenerative phase that diminishes within the first week after birth. Both mammalian and zebrafish heart regeneration is characterized by increased CM proliferation associated with sarcomere disassembly, attributed to a CM dedifferentiation process ([@bib36]; [@bib22], [@bib21]; [@bib35]).

Recent studies with diverse cell types indicate that the rigidity of the underlying (or surrounding) matrix strongly influences cell structure, cytoskeletal organization, migration, polarization, and regulation of gene expression and cell fate ([@bib34]; [@bib11]; [@bib14]; [@bib47]; [@bib13]; [@bib15]; [@bib38]; [@bib40]). In particular, it was demonstrated that interaction with rigid surfaces (hundreds of kPa and stiffer) promotes the formation of large, integrin-mediated adhesions, and consequently, development of a well-organized and polarized cytoskeleton ([@bib38]). Following this logic, we tested here the hypothesis that the decline in CM proliferative and regenerative capacities can be attributed to changes in the mechanical properties of the pericellular environment, which facilitate the assembly of a tightly organized myoskeletal structure. We hypothesize that matrix stiffening, which occurs in the heart after birth, and even more so following MI, is part of a mechanism that blocks CM cell cycle activity.

In this study, we discovered that soft matrices promote CM dedifferentiation, as evidenced by CM rounding, myofibrillar disassembly, increased CM cell division, and clonal expansion. In contrast, a rigid matrix facilitates CM differentiation, characterized by tightly packed arrays of long and aligned sarcomeric bundles, cell cycle arrest, and binucleation. Furthermore, we demonstrated that matrix rigidity specifically affects CM cytokinesis, but not karyokinesis. We next demonstrated that disruption of the highly organized architecture of the CM myoskeleton, using the myosin-II inhibitor blebbistatin, induced CM cell cycle re-entry. We suggest that the mechanical properties of the postnatal heart play a key role in the acquisition of the fully differentiated phenotype, and inhibition of the specialized contractile system in CMs could be used to promote CM dedifferentiation.

Results {#s2}
=======

Compliant substrates promote cardiomyocyte morphological changes and proliferation {#s2-1}
----------------------------------------------------------------------------------

To study the effect of matrix rigidity on CM cellular characteristics, we plated newborn (P1) rat CMs on PDMS substrates with different rigidities, ranging from stiff (2 MPa) to compliant (20 kPa and 5 kPa), and analyzed the sarcomeric and cellular organization. Myosin heavy chain (MHC), Myomesin (an M-band protein) and cardiac Troponin T (cTnT) were expressed in CMs cultured on both rigid and compliant substrates; however, CMs on the rigid substrate displayed aligned sarcomeres with defined and registered striations, whereas CMs on the compliant substrate had disorganized sarcomeres, with misaligned myoskeletal structures ([Figure 1A](#fig1){ref-type="fig"}). Furthermore, CMs cultured on the rigid substrate appeared larger, elongated, and mostly triangular, whereas CMs on the compliant substrate were round, smaller, and less polarized. CMs cultured on the 20 kPa substrate had intermediate parameters in terms of their polarization and spreading morphologies, compared to the 2 MPa and the 5 kPa substrates ([Figure 1B--D](#fig1){ref-type="fig"}).10.7554/eLife.07455.003Figure 1.Compliant substrates alter neonatal cardiomyocyte cell shape and sarcomeric organization, and promote their proliferation.(**A**) Representative images of the sarcomeric patterns of MHC (top), myomesin (middle), and cTnT (bottom) on rigid 2 MPa (left) and soft 5 kPa (right) substrates. Scale bar: 20 µm. (**B**) An overview of neonatal P1 rat CMs on rigid (left) and soft substrates (right). Scale bar: 50 µm. (**C**) Axial ratio of P1 rat CMs (**D**) Cell area of P1 rat CMs (n = 1,108, for **C**, **D**). (**E**, **F**) Representative immunofluorescence images of proliferating P1 rat CMs on various PDMS substrates. Scale bar: 20 µm. CMs were stained for (**E**) sarcomeric cTnT and proliferation marker Ki67, or (**F**) cardiac MHC and PH3 (PH3+/MHC+ are denoted with arrows). (**G**) Quantification of Ki67+/cTnT+ P1 rat CMs on different rigidities (n = 4,165). (**H**) Quantification of PH3+/MHC+ P1 rat CMs on different rigidities (n = 1,964) (**I**) Representative images of neonatal P1 mouse CMs on 2 MPa, 20 kPa, and 5 kPa substrates. (**J**) Quantification of Ki67+/cTnT+ P1 mouse CMs on different rigidities (n = 11,876). Statistical significance was determined using ANOVA followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) if p \< 0.05, two (\*\*) if p \< 0.01, and three (\*\*\*) if p \< 0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.003](10.7554/eLife.07455.003)10.7554/eLife.07455.004Figure 1---figure supplement 1.Compliant substrates alter P1 mouse cardiomyocyte cell shape, polarity, and sarcomeric organization.(**A**) Cell area of P1 mouse CMs cultured on rigid and compliant substrates (n = 1,118). (**B**) Axial ratio of CMs on the different substrates (n = 1,115). (**C**) Cell perimeters of CMs (n = 1,131). Statistical significance was determined using ANOVA, followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) for p \< 0.05.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.004](10.7554/eLife.07455.004)

To determine the effects of substrate rigidity on CM proliferation, we stained CMs with the cell-cycle markers Ki67 and phospho-histone-3 (PH3), together with cTnT and MHC ([Figure 1E,F](#fig1){ref-type="fig"}). Proliferating CMs were observed on all tested matrices (Ki67+/cTnT+, and PH3+/MHC+) ([Figure 1E,F](#fig1){ref-type="fig"}, respectively). CMs cultured on either glass or on the stiff (2 MPa) substrate presented similar proliferative capacities (data not shown). However, CM proliferation was increased on the compliant substrates (5 kPa and 20 kPa) by ∼50--65%, respectively, relative to the rigid substrate ([Figure 1G](#fig1){ref-type="fig"}, visualized with Ki67), and by ∼25--110% on the 5 kPa and 20 kPa substrates, respectively, marked by PH3+ MHC+ CMs ([Figure 1H](#fig1){ref-type="fig"}). Taken together, these findings suggest that myoskeletal disassembly, a tendency toward cell rounding, and increased CM proliferation are more compatible with compliant matrices, in comparison with the rigid matrix.

Inspired by the important finding of the transient regenerative potential in the neonatal mouse heart ([@bib35]), we established a mouse culture system of P1 neonatal CMs cultured on 2 MPa, 20 kPa, and 5 kPa substrates. As in rat CMs, mouse neonatal CMs grew on all substrates, and developed normal beating within 48--72 hr after seeding. We quantified the percentage of proliferating Ki67+ cTnT+ CMs, and observed that both the 5 kPa and 20 kPa substrates facilitated CM proliferation by ∼30--50%, respectively, relative to the rigid 2 MPa substrate ([Figure 1I,J](#fig1){ref-type="fig"}). There was no significant difference in the area of cells plated on the different substrates ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Similar to the rat system, CMs cultured on the rigid substrate were elongated and more polarized, compared to those on the compliant substrates ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). A decrease in CM cell perimeter, indicative of roundness, was observed on the compliant substrates, compared to the rigid one ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Hence, compliant substrates promote CM proliferation as well as alterations in CM cell shape, in both rat and mouse neonatal cultures.

Distinct rigidity-dependent cardiomyocyte proliferation mechanisms {#s2-2}
------------------------------------------------------------------

Various proliferation markers (e.g., Ki67 shown in [Figure 2A](#fig2){ref-type="fig"}, BrdU, PH3, and Aurora B), are widely used for cell-cycle assessment and quantification of cell proliferation; however, they sometimes prove insufficient, especially in CMs in which polyploidization and binucleation are natural outcomes of cell proliferation in the postnatal period ([@bib6]; [@bib49]). In order to explore the effects of matrix rigidity on CM cell division and the formation of new CMs, we established a live-cell imaging system of CMs derived from transgenic mice expressing the R26R-tdTomato reporter under the regulation of the *Myh6* promoter (*Myh6-Cre;R26R-tdTomato-lox)* ([Figure 2B](#fig2){ref-type="fig"}). Live-cell video microscopy revealed two distinct CM cell-cycle phenotypes: karyokinesis followed by binucleation ([Figure 2C](#fig2){ref-type="fig"}, [Video 1](#video1){ref-type="other"}), as opposed to karyokinesis followed by cytokinesis, resulting in the formation of two new CMs ([Figure 2D](#fig2){ref-type="fig"}, [Video 2](#video2){ref-type="other"}). In the first, CMs were relatively large, spread, and immotile ([Figure 2C](#fig2){ref-type="fig"}: 50′, 60′). These CMs underwent karyokinesis, leading to the formation of binucleated CMs ([Figure 2C](#fig2){ref-type="fig"}: 50′, 60′), while remaining well spread and attached to the substrate ([Figure 2C](#fig2){ref-type="fig"}).10.7554/eLife.07455.005Figure 2.Distinct rigidity-dependent cardiomyocyte division mechanisms.(**A**) Immunofluorescent images of dividing neonatal CMs in culture. The newly formed CMs are still connected, and both nuclei are Ki67+ (red). (**B**) A schematic drawing of the experimental design. (**C**) Video frames of a P1 *Myh6-Cre;R26R-dTomato-lox* CM undergoing karyokinesis followed by binucleation, without changing its morphology. (Inset) A fibroblast undergoing typical cell division. (**D**) Video frames of a P1 *Myh6-Cre;R26R-dTomato-lox* CM undergoing karyokinesis, followed by complete cytokinesis. The original CM is highlighted in 0′. The two new CMs are highlighted in 120′. Yellow arrows mark karyokinesis (20′, 30′); white arrows mark the new nuclei (40′), or new CM (60′,110′). (**E**) P1 mouse CM karyokinesis on different rigidities. (**F**) P1 mouse CM cytokinesis on different rigidities. (**G**) P1 mouse CM binucleation on different rigidities (n = 2,167 for **E**, **F**, **G**). (**H**) Quantification of new CMs on different rigidities (n = 2,878). Statistical significance was determined using ANOVA followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) if p \< 0.05, and two (\*\*) if p \< 0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.005](10.7554/eLife.07455.005)10.7554/eLife.07455.006Figure 2---figure supplement 1.Binucleated cardiomyocytes re-enter the cell cycle.(**A**) A binucleated P1 *Myh6-Cre;R26R-dTomato-lox* CM (highlighted) re-enters the cell cycle, but fails to divide, and remains binucleated. (**B**) A binucleated P1 *Myh6-Cre;R26R-dTomato-lox* CM (highlighted) re-enters the cell cycle, changes its morphology, and divides, forming new CMs. (**C**) A schematic drawing of binucleated CM cell cycle re-entry; however, the CM remains binucleated. (**D**) A schematic drawing of a binucleated CM re-entering the cell cycle, undergoing rounding, and completing cytokinesis, to form new CMs. (**E**) Binucleated CMs cell-cycle re-entry events occurring on matrices of varying rigidities.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.006](10.7554/eLife.07455.006)Video 1.Mouse cardiomyocyte binucleation.A 24 hr time-lapse video of a representative P1 *Myh6-Cre;R26R-dTomato-lox* CM undergoing karyokinesis followed by binucleation. Time-lapse-10 min. Scale bar: 30 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.007](10.7554/eLife.07455.007)10.7554/eLife.07455.007Video 2.Mouse cardiomyocyte cytokinesis.A 48 hr time-lapse video of a representative P1 *Myh6-Cre;R26R-dTomato-lox* CM undergoing karyokinesis followed by cytokinesis. Time-lapse-10 min. Scale bar: 30 µm. One of the mononucleated daughter cells undergoes consecutive cell division, and karyokinesis followed by cytokinesis.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.008](10.7554/eLife.07455.008)10.7554/eLife.07455.008

In contrast, CMs that completed cell division (cytokinesis) underwent a step of mitotic rounding ([Figure 2D](#fig2){ref-type="fig"}), which is common for most proliferating cells ([@bib24]); moreover, these CMs often underwent consecutive cell divisions. Strikingly, we found that compliant matrices did not affect nuclear cell division (karyokinesis), yet promoted cytokinesis and inhibited CM binucleation prominence, as determined by quantification of the division frequency, observed by live-cell imaging ([Figure 2E--G](#fig2){ref-type="fig"}).

In order to demonstrate an actual increase in CM number, we quantified the amount of CMs at the beginning and after 48 hr. A significant increase in the number of newly formed CMs was observed on the 20 kPa substrate, relative to the rigid 2 MPa ([Figure 2H](#fig2){ref-type="fig"}). Interestingly, we could observe rare events of cytokinesis even in binucleated CMs cultured on the 20 kPa substrate, resulting in two daughter CMs ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}). These successful events were also accompanied by mitotic rounding ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Taken together, our findings demonstrate that culturing CMs on compliant matrices facilitate CM cell rounding and division (cytokinesis) that lead to formation of new CMs. In contrast, our results demonstrated that the rigid matrix promotes karyokinesis without cytokinesis, leading to CM binucleation ([Figure 2G](#fig2){ref-type="fig"}).

Compliant matrices promote cardiomyocyte dedifferentiation {#s2-3}
----------------------------------------------------------

To further investigate the molecular status of CMs undergoing cytokinesis, we designed an assay that enabled us to correlate between the live imaging videos, in which we could visualize cell division processes ([Figure 2](#fig2){ref-type="fig"}), with molecular and lineage analyses of the dividing cells ([Figure 3](#fig3){ref-type="fig"}). Accordingly, correlated live cell-immunofluorescence microscopy was performed on CMs derived from P1 transgenic *Myh6-Cre;R26R-tdTomato-lox* mice cultured on 2 MPa, 20 kPa and 5 kPa substrates in grid-containing plates. The 'Tomato' cells represent CMs that express, or previously expressed, the Myh6 gene, a signature of CM differentiation. Under regular conditions, we detected almost 100% of dTomato+/cTnT+ double positive CMs ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).10.7554/eLife.07455.009Figure 3.Compliant matrices induce cardiomyocyte dedifferentiation.(**A**--**C**) Correlative live-cell-immunofluorescence of CM dedifferentiation on (**A**) 2 MPa, (**B**) 20 kPa, and (**C**) 5 kPa matrices. Recently divided P1 *Myh6-Cre;R26R-dTomato-lox* CMs, following time-lapse imaging (**A**, **B**, **C**, left panel, and **A′**, **B′**, **C′**), correlated with the expression of cTnT (**A′′**, **B′′**, **C′′**), and Ki67 (**A′′′**, **B′′′**, **C′′′**). CMs following cell division are denoted with white arrows. (**D**) An overview of a field of P1 *Myh6-Cre;R26R-dTomato-lox* CMs (red, left panel), immunostained for cTnT (green, middle panel), and a merge of Tomato+/cTnT− images (right panel). Scale bar: 50 µm. (**E**) Quantification of Tomato+/cTnT− CMs on 2 MPa, 20 kPa, and 5 kPa (n = 19,869). (**F**) An overview of a field of P1 *Myh6-Cre;R26R-dTomato-lox* CMs (red, left panel), immunostained for MHC (green, middle panel), and a merge of the Tomato+/MHC− images (right panel). Scale bar: 20 µm. (**G**) Quantification of Tomato+/MHC− CMs on 2 MPa, 20 kPa, and 5 kPa substrates. Scale bar: 20 µm (n = 13,474). (**H**) P1 *Myh6-Cre;R26R-dTomato-lox*/cTnT− CMs expressing Nkx2.5. (**I**) Schematic diagram showing CM dedifferentiation from a mature to an immature proliferative state, facilitated by compliant matrices. Statistical significance was determined using ANOVA followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) if p \< 0.05.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.009](10.7554/eLife.07455.009)10.7554/eLife.07455.010Figure 3---figure supplement 1.dTomato cardiomyocytes express cTnT.(**A**, **B**) Representative image of P1 *Myh6-Cre;R26R-dTomato-lox*-derived CMs co-stained with cTnT antibody (**A**), and their quantification showing less than 1% of Tomato+/cTnT negative CMs (**B**).**DOI:** [http://dx.doi.org/10.7554/eLife.07455.010](10.7554/eLife.07455.010)

Time-lapse imaging was performed for 48 hr, and immediately thereafter, cultures were fixed and immunostained for cTnT and Ki67. We first examined the time-lapse videos for CMs undergoing complete cell division (karyokinesis plus cytokinesis), and identified the two daughter cells by using the grid coordinates ([Video 3--5](#video3 video4 video5){ref-type="other"}). By correlating the last frame of each time-lapse video ([Figure 3A--C](#fig3){ref-type="fig"}) with cTnT staining, we revealed that the dividing CMs (tdTomato positive; [Figure 3A′,B′,C′](#fig3){ref-type="fig"}) lost cTnT expression, either completely ([Figure 3A′′,B′′](#fig3){ref-type="fig"}), or partially ([Figure 3C′′](#fig3){ref-type="fig"}). This result is consistent with a CM dedifferentiation process, in which CMs, originating from the Myh6 lineage, lost cTnT expression ([Figure 3A′′,B′′,C′′](#fig3){ref-type="fig"}). Furthermore, the majority of these cells expressed Ki67 on all three matrices, indicating that these CMs maintain a proliferative potential ([Figure 3A′′′,B′′′,C′′′](#fig3){ref-type="fig"}).Video 3.Mononucleated cardiomyocyte cytokinesis on a 2 MPa substrate.48 hr time-lapse imaging (with 10 min intervals) of P1 *Myh6-Cre;R26R-dTomato-lox* CMs on a 2 MPa substrate. Scale bar: 30 µm. The last frame of this video is shown in [Figure 3A](#fig3){ref-type="fig"}, and was correlated with immunofluorescence staining, as shown in [Figure 3A′′,A′′′](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.011](10.7554/eLife.07455.011)10.7554/eLife.07455.011Video 4.Mononucleated cardiomyocyte cytokinesis on a 20 kPa substrate.48 hr time-lapse imaging (with 10 min intervals) of P1 *Myh6-Cre;R26R-dTomato-lox* CMs on a 20 kPa substrate. Scale bar: 30 µm. The last frame of this video is shown in [Figure 3B](#fig3){ref-type="fig"}, and was correlated with immunofluorescence staining, as shown in [Figure 3B′′,B′′′](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.012](10.7554/eLife.07455.012)10.7554/eLife.07455.012Video 5.Mononucleated cardiomyocyte cytokinesis on a 5 kPa substrate.48 hr time-lapse imaging (with 10 min intervals) of P1 *Myh6-Cre;R26R-dTomato-lox* CMs on a 5 kPa. Scale bar: 30 µm. The last frame of this video is shown in [Figure 3C](#fig3){ref-type="fig"}, and was correlated with immunofluorescence staining, as shown in [Figure 3C′′,C′′′](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.013](10.7554/eLife.07455.013)10.7554/eLife.07455.013

To quantify CM dedifferentiation on the different matrix rigidities, we performed immunofluorescence analysis of P1 CMs cultured on the different substrates. We counted the number of tdTomato+/cTnT− CMs ([Figure 3D,E](#fig3){ref-type="fig"}) or MHC− ([Figure 3F,G](#fig3){ref-type="fig"}). A ∼twofold increase in CM dedifferentiation (Tomato+/cTnT− and Tomato+/MHC−) was observed on the 20 kPa, and an ∼1.5-fold increase, on the 5 kPa matrices, relative to the rigid matrix ([Figure 3E,G](#fig3){ref-type="fig"}). Moreover, all Myh6 lineage-positive (tdTomato+) CMs in the culture expressed Nkx2.5, indicating that these cells derived from the cardiac lineage ([Figure 3H](#fig3){ref-type="fig"}). Our findings, showing dividing CMs that downregulated cTnT and/or MHC sarcomeric proteins and express Nkx2.5, strongly suggest that the compliant matrices promote the dedifferentiation of CMs, consistent with their role in promoting cytokinesis ([Figure 3I](#fig3){ref-type="fig"}).

Relaxation of the acto-myosin system induces cardiomyocyte proliferation {#s2-4}
------------------------------------------------------------------------

Our findings thus far suggest that disruption of the CM myoskeleton promotes CM cell cycle re-entry. We therefore tested whether inhibition of the CM myoskeleton function could boost CM proliferation. For that purpose, we used blebbistatin, a small molecule myosin II inhibitor that effectively blocks the actin-myosin interaction in several striated muscle (including CMs), in smooth muscle, and in non-muscle cells ([@bib12]). Neonatal mouse CMs were cultured on PDMS substrates with the different rigidities, left to adhere for 72 hr, and then treated with 20 µM blebbistatin for 24 hr. After 24 hr of treatment, we fixed the cells and immunostained them for cTnT and Ki67. We found that blebbistatin severely disrupted CM myoskeleton morphology, leading to massive changes in CM cell shape, manifested by major flattening, dramatic fragmentation of the sarcomeric arrays, and complete loss of striations ([Figure 4A,B](#fig4){ref-type="fig"}).10.7554/eLife.07455.014Figure 4.Blebbistatin induces CM proliferation.(**A**, **B**) Representative images of P1 mouse CMs cultured in the absence of blebbistatin (**A**), or presence of 20 µM blebbistatin (**B**), on 2 MPa (top), 20 kPa (middle), and 5 kPa (bottom) substrates. Scale bar: 20 µm. (**C**) Quantification of Ki67+/cTnT+ P1 mouse CMs on different rigidities in the presence or absence of 20 µM blebbistatin (n = 25,554). Statistical significance was determined using ANOVA followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) if p \< 0.05, and two (\*\*) if p \< 0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.014](10.7554/eLife.07455.014)

We next analyzed CM proliferation in the presence or absence of blebbistatin, by quantifying the percentage of Ki67+/cTnT+ CMs ([Figure 4C](#fig4){ref-type="fig"}). This analysis indicated that blebbistatin-treated CMs display higher cell cycle activity compared to control (untreated) CMs on the 2 MPa and 20 kPa rigidities ([Figure 4C](#fig4){ref-type="fig"}). Hence, we conclude that relaxation of the acto-myosin myoskelton in CMs by blebbistatin promotes cell cycle re-entry. The lack of blebbistatin effect on the 5 kPa substrate is consistent with the relaxed CM morphology induced by the 5 kPa substrate in the absence of blebbistatin. Taken together, these results suggest that complaint matrices promote CM proliferation primarily via their effect on myoskeletal organization.

A compliant (20 kPa) matrix promotes clonal expansion of mature cardiomyocytes {#s2-5}
------------------------------------------------------------------------------

A closer examination of CMs derived from the Myh6 lineage that were grown on the 20 kPa matrix and lost cTnT and/or MHC expression, revealed clusters of cells (more than 2), suggesting that these cells were derived from a common CM that underwent multiple cell divisions ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). To explore this notion further, we took advantage of the *R26R-Confetti* reporter line ([@bib42]). In this setting, the *R26R-Confetti* reporter generated stochastic, multicolor Myh6 lineage-derived CMs with four fluorescent proteins, each marking individual clones ([Figure 5A--F](#fig5){ref-type="fig"}; high magnification areas showing heterogeneous multicolor CM clones in vivo D, E, or individual YFP+ CM clones in F). To asses the clonal potential of CMs grown on the different rigidities, we cultured P1 CMs derived from *Myh6-Cre;R26R-Confetti-lox* hearts, and imaged them at 4, 5, 7, 8 9, and 11 days in culture. At each time point, the exact same fields were imaged, in order to enable the tracing of CM cell division and clonal expansion. Unicolor clones, likely originating from a single CM, were identified on all three rigidities.10.7554/eLife.07455.015Figure 5.The compliant 20 kPa matrix promotes cardiomyocyte clonal expansion.(**A**) A schematic drawing of the clonal tracing strategy of *Myh6-Cre;R26R-Confetti-lox* mice. (**B**) In vivo section of a neonatal *Myh6-Cre;R26R-Confetti-lox* heart. Scale bar: 100 µm. (**C**) In vitro culture of *Myh6-Cre;R26R-Confetti-lox*---derived CMs. Scale bar: 20 µm. (**D**--**F**) in vivo images of *Myh6-Cre;R26R-Confetti-lox* heart sections at high magnification. Scale bar: 20 µm. (**D**--**E**) Heterogeneous population of CMs. (**F**) A clone of YFP+ CMs, surrounding a single RFP+ CM. (**G**) 20 kPa substrate facilitates a 2.4-fold increase in CM number, relative to 2 MPa. (**H**) 20 kPa substrate facilitates an increase in the percentage of clones. (**I**) Total number of cells over time on 2 MPa, 20 kPa, and 5 kPa substrates, showing a greater initial number of cells, as well as a greater final number of cells, on 20 kPa substrates (n = 6,401 for G, n = 5,110 for **H**, **I**,). (**J**) Formation of a YFP-positive clone on a 20 kPa substrate, throughout the experiment. Clonal expansion is indicated by an increase in the number of cells. Statistical significance was determined using ANOVA, followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) if p \< 0.05, and two (\*\*) if p \< 0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.015](10.7554/eLife.07455.015)10.7554/eLife.07455.016Figure 5---figure supplement 1.Formation of dedifferentiated cardiomyocyte clones on a 20 kPa matrix.A cluster of Tomato+/cTnT−/Nkx2.5+ expressing cells (more than 2) on a 20 kPa matrix, suggesting clonal behavior of cells derived from a common CM (or a few CMs) that underwent multiple cell divisions (circled clone). Scale bar: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.016](10.7554/eLife.07455.016)10.7554/eLife.07455.017Figure 5---figure supplement 2.Clonal behavior of individual P1 *Myh6-Cre;R26R-Confetti-lox*---derived cardiomyocytes on different rigidities.Development of P1 *Myh6-Cre;R26R-Confetti-lox* -derived clones at different time points, on matrices with rigidities of 2 MPa (left), 20 kPa (middle), and 5 kPa (right).**DOI:** [http://dx.doi.org/10.7554/eLife.07455.017](10.7554/eLife.07455.017)

We quantified the total amount of CMs that were formed between day 4 and day 11, the percentage of single-color clones, and the number of cells in each clone, for each of the three rigidities ([Figure 5G--I](#fig5){ref-type="fig"}, respectively. [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). We found ∼2.4-fold higher numbers of total CMs formed on the 20 kPa relative to the 2 MPa substrate ([Figure 5G](#fig5){ref-type="fig"}). A ∼twofold increase in the percentage of unicolor clones was observed on the 20 kPa substrate, compared to both the rigid 2 MPa and softest 5 kPa substrates ([Figure 5H](#fig5){ref-type="fig"}).

Next, we quantified the number of cells in all the clones, at each time point, and found that the 20 kPa matrix induced an impressive increase in CM cell number ([Figure 5I](#fig5){ref-type="fig"}). A typical clonal expansion of an individual YFP-positive clone, from only 2 cells at Day 4, to 9 cells within a week (Day 11), is shown ([Figure 5J](#fig5){ref-type="fig"}). This analysis revealed that neonatal CMs can undergo clonal expansion in vitro, a process which involves multiple cell divisions; moreover, this potential can be induced most readily on the 20 kPa matrix, compared to either rigid or softer matrices.

Discussion {#s3}
==========

In this study, we explored the effect of the microenvironment, specifically its rigidity, on CM cell fate, with an emphasis on CM proliferation and dedifferentiation. Notably, most studies that address the impact of rigidity on cell fate decisions have focused on the differentiation processes ([@bib13]; [@bib19]; [@bib4]; [@bib7]). The terminology and characteristics of the reverse process are much less clear, but generally refer to the shift from a differentiated to a less-differentiated cellular stage within the same lineage ([@bib21]). Here, we show that neonatal CMs cultured on compliant (compared to rigid) 2D matrices lose several key manifestations commonly associated with postnatal cardiac muscle differentiation in vivo, such as robust, well-aligned myoskeletel organization, expression of differentiation genes, and cell cycle arrest. Hence, we conclude that compliant substrates promote CM dedifferentiation and proliferation ([Figure 6](#fig6){ref-type="fig"}). In line with these findings, we demonstrated that dedifferentiated CMs were able to undergo clonal expansion, which involves multiple cell divisions, suggesting a shift to a progenitor cell state.10.7554/eLife.07455.018Figure 6.The crosstalk between matrix rigidity and CM cell fate.A schematic model showing the effect of matrix rigidity on CM cell fate. Rigid substrates maintain the differentiated state of CMs, which is incompatible with cytokinesis. Blocked cytokinesis leads to binucleated CMs. A mitotic checkpoint determines the ability of CMs to re-enter the cell cycle. Compliant substrates control a second checkpoint, mechanical in nature, which enables cytokinesis. Compliant substrates induce CM dedifferentiation into a less organized, immature and proliferative state. This state involves cytoskeletal disarrangements leading to CM mitotic rounding, thus enabling cell division.**DOI:** [http://dx.doi.org/10.7554/eLife.07455.018](10.7554/eLife.07455.018)

What is the mechanism underlying the matrix rigidity-dependent CM dedifferentiation process? In particular, we wondered whether there is a clear hierarchy between the mechanical properties of the heart during embryonic and postnatal stages. We propose that the rigidification of the heart after birth from 10-20 kPa to 40--55 kPa ([@bib5]; [@bib13]; [@bib18]) promotes CM terminal differentiation by triggering the formation of a rigid myoskeleton that mechanically interferes with CM cytokinesis, without affecting karyokinesis. Ultimately, this physiological transition leads to an accumulation of binucleated CMs, correlating with the transition from embryonic hyperplastic growth of CMs, to postnatal hypertrophic growth ([Figure 6](#fig6){ref-type="fig"}).

It was previously shown that CM shape is linked to sarcomeric alignment ([@bib8]); circular CMs do not assemble actin networks or sarcomeric arrays, whereas rectangular CMs do. Consistent with this, we show high polarity and organization of triangular CMs on rigid substrates, as opposed to low polarity, roundness, and disorganized sarcomeres on compliant substrates. Eukaryotic cell division requires cellular and cytoskeletal remodeling: cells become round and spherical upon entering mitosis ([@bib17]; [@bib25]). This mitotic rounding is, to some extent, considered a hallmark of cell division, and the interplay between the actin cytoskeleton, cell shape, and the developing mitotic spindle are all involved in this rounding ([@bib9]; [@bib24]). Thus, it appears that cytoskeletal organization and cell-cycle control are linked together.

In line with this notion, we demonstrate that inhibition of the organized CM contractile apparatus following blebbistatin treatment resulted in increased CM cell cycle re-entry. We show an increase in Ki67-expressing CMs in the presence of blebbistatin on the 2 MPa and 20 kPa rigidities. Blebbistatin treatment strongly perturbed CM myoskeletal organization and consequently induced CM cell cycle activity, suggesting that the development of a robust myoskeleton in CMs is linked to their cell cycle arrest. We suggest that compliant matrices promote CM proliferation primarily via their effect on the organization of the myoskeleton. More broadly, we propose that the rigid matrix increases the forces imposed on the CMs\' actin myoskeleton and this facilitates CM differentiation, while inhibition of sarcomeric organization, function and contractility by blebbistatin has the opposite effect, eventually, leading to CM dedifferentiation. That said, it was previously shown that long blebbistatin treatment inhibits cell division, leading to generation of polyploid megakaryocytes ([@bib40]). Polyploidity and binucleation are natural outcomes of postnatal CM proliferation events ([@bib49]). It is possible that the high CM cell-cycle activity observed in the presence of blebbistatin may ultimately result in inhibition of cytokinesis, leading to CM binucleation, or even multinucleation.

One of the most important findings in this study is that cytokinesis, but not karyokinesis, is affected by matrix rigidity: it is facilitated by the compliant substrates, or inhibited by the rigid substrate. Taken together, the data presented here suggest that committed CMs cultured on the 20 kPa (and, to some extent, the 5 kPa) substrate lose the environmental mechanical barrier, leading to the disorganization of the myoskeleton, which facilitates the acquisition of a rounded morphology compatible with cytokinesis and cell division ([Figure 6](#fig6){ref-type="fig"}).

The mechanisms underlying CM binucleation, due to failure to complete cytokinesis, are poorly understood. Recently, the view that binucleated CMs cannot divide was challenged, showing that a proliferative burst on P15, induced by a thyroid hormone surge, led to a 1.4-fold increase in CM number ([@bib31]). We observed rare events of binucleated CMs attempting to divide, though most remain binucleated. However, the few successful division events were facilitated by growth on the 20 kPa matrix, further supporting the notion that CM can respond to matrix rigidity. Interestingly, transgenic expression of a constitutively active (ca) form of ErbB2 in mouse CMs during the neonatal and adult periods could stimulate CM division, expanding the postnatal proliferative and regenerative windows into adulthood. Stimulation of CM division by caErbB2 involved both CM dedifferentiation, and hypertrophy leading to cardiomegaly. In line with the observed dedifferentiation phenotype, caErbB2 signaling promoted proliferation of mono- and bi-nucleated CMs ([@bib10]).

In other model systems, rigidity was shown to influence proliferation and stemness of cells. In line with our data, mouse embryonic fibroblasts (MEFs), vascular smooth muscle cells (VSMCs), and MCF10A cells proliferate best on ∼24 kPa ([@bib23]). Moreover, muscle stem cells (MuSCs) that were cultured on a soft substrate that mimics muscle tissue rigidity (∼12 kPa) display delayed differentiation, self-renewal, and maintained stemness ([@bib16]). In agreement with our findings, these researchers propose that decreased rigidity preserves stemness by altering cell shape, resulting in cytoskeletal rearrangements.

In both neonatal mice and adult zebrafish, cardiac regeneration processes were accompanied by loss of sarcomeric structures and re-acquisition of cell division, both attributed to CM dedifferentiation ([@bib36]; [@bib22]; [@bib35]). Our correlative live-imaging and immunostaining results support the notion that dedifferentiated CMs disassemble their sarcomeres, in order to divide.

The fact that CMs have lost MHC or cTnT expression, and the partial disassembly of the sarcomeres during cytokinesis, further support our model of CM dedifferentiation, rather than the presence of progenitor cells. The *Myh6-Cre;R26R-confetti-lox* system enabled us to document clonal behavior in neonatal CMs. We show that clonal expansion is rigidity-dependent, with an optimal clonal efficiency on the 20 kPa. Clone formation originated at various time points and progressed at different rates, suggesting a continuous proliferative capacity, rather than a final 'burst' of proliferation. Whether neonatal or adult CMs are capable of undergoing multiple cycles of cell division in vivo, has yet to be determined.

Our findings bear obvious relevance for cardiac regeneration after injury. In this unfortunate event, CMs in the vicinity of the scar tissue sense a stiffer environment, compared to the healthy adult heart ([@bib18]). Thus, if fully differentiated CMs present in the vicinity of the damaged area, can still maintain the capacity to dedifferentiate and resume cell division if confronted with a sufficiently compliant scaffold, a new avenue toward the regeneration of heart tissue may be opened.

Materials and methods {#s4}
=====================

Isolation and culture of neonatal rat cardiomyocytes {#s4-1}
----------------------------------------------------

Experiments were approved by the Animal Care and Use Committee of the Weizmann Institute of Science. Neonatal rat CMs were isolated and cells were cultured, as previously described ([@bib41]). Briefly, 1-day-old newborn Wistar rats were decapitated; the hearts were harvested, cut into small pieces (1--2 mm), and washed several times in phosphate-buffered saline (PBS) to remove excess blood. To obtain a CM-rich culture, the hearts were digested in RDB, a proteolytic enzyme extracted from the fig tree (Biological Institute, Nes Ziona, Israel) in 6--8 cycles of 10 min each, at room temperature. The cells were centrifuged at 1500 rpm for 5 min. The pellet was resuspended and cultured in a 10 cm dish for 30 min-1 hr for pre-plating, to produce a CM-rich culture. CMs were then cultured on glass or PDMS surfaces. CMs began to beat spontaneously within 2--3 days, on all of the tested substrates.

Isolation and culture of neonatal mouse cardiomyocytes {#s4-2}
------------------------------------------------------

CM isolation was performed using the Neonatal Heart Dissociation Kit (gentleMACS, Miltenyi Biotec, Auburn, CA, USA). CMs were cultured in DMEM/F12 containing Na-pyruvate, non-essential amino acids, penicillin (100 U/ml), streptomycin (100 μg/ml), 2 mM L-glutamine, 5% horse serum, and 20% fetal bovine serum (FBS). Briefly, 1-day-old newborn wild-type (WT) or *Myh6-Cre;R26R-tdTomato-lox* CMs were decapitated; the hearts were harvested and transferred into a 10 cm dish containing PBS, and remaining blood was carefully pumped. Hearts were transferred into the gentleMACS C Tube, and enzyme mix was added. C Tubes containing hearts and enzyme mix were incubated for 15 min at 37 °C, transferred to the gentleMACS Dissociator, and the gentleMACS Program 'mr_neoheart_01' was run. These incubation and dissociation steps were repeated 2--3 times. C tubes containing hearts were centrifuged at 2000 rpm for 5 min. The pellet was resuspended and cultured in a 10 cm dish for 30 min-1 hr for pre-plating, to produce a CM-rich culture. CMs were then cultured on fibronectin-coated PDMS surfaces. CMs began to beat spontaneously within 2--3 days, on all of the tested substrates.

Transgenic animals {#s4-3}
------------------

For live-cell imaging and imuunofluorescence assays of Myh6-expressing cells, we crossed mice carrying the Cre coding sequence inserted after the alpha myosin heavy chain promoter (Myh6-cre), which can drive high-efficiency gene recombination in CMs ([@bib1]), with ROSA26-flox-STOP-tdTomato indicator mice (R26R-tdTomato) ([@bib29]), thus creating red fluorescent-labeled CMs that could be tracked. For clonal analysis of Myh6-expressing cells, Myh6-Cre mice were crossed with the ROSA26-flox-STOP-Confetti reporter mice ([@bib42]). ROSA26-flox-STOP-Confetti reporter mice (R26R-confetti reporter mice) were kindly provided by Dr. Shalev Itzkovitz, Weizmann Institute of Science.

Clonal analysis of Myh6-expressing cells {#s4-4}
----------------------------------------

*Myh6-Cre;R26R-confetti-lox* CMs were cultured on different PDMS matrices on grid-bottomed MatTek dishes. Using a DeltaVision Elite system (Applied Precision, USA) on an Olympus IX71 inverted microscope, running softWoRx 6.0, fluorescence images were acquired at 10× or 20× magnifications, by a CoolSnap HQ2 CCD camera (Roper Scientific, USA). For clonal analysis, we utilized the DeltaVision collect panels option. Panel stitching was performed using softWoRx.

Preparation of substrates of varying rigidities {#s4-5}
-----------------------------------------------

Polydimethylsiloxane (PDMS) substrates of varying rigidities were prepared, using a Sylgard 184 silicone elastomer kit (Dow Corning, USA). The silicone elastomer component was mixed with the curing agent, degassed, and spin-coated at 2000 rpm for 2 min with a Spin Processor WS-650MZ-23NPP/LITE (Laurell Technologies) on MatTek \#0, \#1 or MatTek \#1.5 glass-bottomed dishes (MatTek Corporation), or microscopy coverslips (Electron Microscopy Science) for live-cell and for immunofluorescence experiments, or MatTek gridded \#2 glass-bottomed dishes for the correlation live-cell immunofluorescence experiments, to obtain a 35 ± 5 μm-thick PDMS layer. Subsequently, crosslinking of the elastomer was carried out at 70°C overnight. The compliance of the PDMS substrates was verified by using the methodology as previously described ([@bib38]). Briefly, polymerized slabs of PDMS were used for bulk measurements of Young\'s moduli, using an Instron universal testing machine (Instron). Elastomer to curing agent ratios of 10:1, 50:1 and 75:1 corresponded to Young\'s moduli of 2 MPa, 20 kPa and 5 kPa, respectively. Dishes with a layer of PDMS were functionalized with 20 μg/ml fibronectin at 4°C overnight. Before cell plating, plates were washed with PBS and growth medium.

Drug treatment {#s4-6}
--------------

CMs were cultured for 72 hr, and then treated with the myosin II inhibitor blebbistatin (20 µM, Sigma) for 24 hr. Following blebbistatin treatment, cells were permeabilized, fixed, and immunostained for sarcomere and proliferation markers.

Immunocytochemistry {#s4-7}
-------------------

Cells were permeabilized with 3% paraformaldehyde (PFA) in PBS containing 0.25% Triton X-100 for 3 min, and then fixed with 3% PFA in PBS for 20--30 min, washed 3 times in PBS, blocked with 10% goat serum in PBS, and stained for the following sarcomeric markers: cardiac troponin T (cTnT, abcam); MF20 (MHC, Myosin heavy chain Developmental Studies Hybridoma Bank \[DSHB\]); cardiac MHC (Abcam); myomesin (DSHB); Nkx2.5 (Abcam), and the following proliferation markers: Ki67 (Abcam) and phospho-histone-3 (PH3, Santa Cruz). Secondary antibodies used were Alexa-488, Cy3, Alexa- 647, conjugated anti-mouse IgG1, and Cy5-conjugated anti-mouse IgG2b. Cells were also stained for DAPI, to visualize the nuclei.

Fluorescence microscopy and live-cell imaging {#s4-8}
---------------------------------------------

Live-cell imaging and sample examination were performed using a DeltaVision Elite system (Applied Precision, USA), on an Olympus IX71 inverted microscope, running softWoRx 6.0. Fluorescent images were acquired at 10×, 20×, 40× and 60× magnifications, by a CoolSnap HQ2 CCD camera (Roper Scientific, USA). Time-lapse imaging was carried out for 24 hr or 48 hr at 10 min intervals, and acquired at a 20× or 10× magnification (20×/0.5NA or 10×/0.3NA objectives). Correlated live-cell immunofluorescence microscopy was performed on gridded \#2 glass-bottomed dishes (MatTek Corporation), using either 10×/0.3NA or the 20×/0.5NA objectives for time-lapse imaging, and the 10×/0.3NA or 20×/0.85NA objectives for immunofluorescence correlation.

Image analysis {#s4-9}
--------------

Images of *Myh6-Cre;R26R-confetti-lox* mice in vivo sections were taken with a Nikon Ti-E inverted fluorescence microscope equipped with a 10×, or 100× oil-immersion objectives and a Photometrics Pixis 1024 CCD camera using MetaMorph software (Molecular Devices, Downington, PA). The image-plane pixel dimension was 1.3 µm for 10× magnification, and 1.3 µm for 100× magnification. CM projected area and best-fit ellipse aspect ratio of cardiac troponin T-stained cells were calculated, using ImageJ software.

Video editing {#s4-10}
-------------

Descriptions, titles and arrows have been added to all videos using 'Final Cut Pro' editing software.

Statistical analysis {#s4-11}
--------------------

Generally, all experiments were carried out with n ≥ 3. In all panels, numerical data are presented as mean +s.e.m. Statistical significance was determined using ANOVA, followed by post-hoc Tukey\'s (HSD) test. Results are marked with one asterisk (\*) if p \< 0.05, two (\*\*) if p \< 0.01, and three (\*\*\*) if p \< 0.001.
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Thank you for submitting your work entitled "Reduced matrix rigidity promotes cardiomyocyte dedifferentiation, proliferation and clonal expansion" for peer review at *eLife*. Your submission has been favorably evaluated by Fiona Watt (Senior Editor), a Reviewing Editor, and three reviewers.

The reviewers have discussed the reviews with one another, and the Reviewing editor has drafted this decision to help you prepare a revised submission

The reviewers were generally favorable about the importance of the study and the conclusions. However, there were several issues that tempered enthusiasm and aspects of the data that did not fully support the conclusions. In particular, issues around the cell types, the rigor with which quantitative analysis is performed, and over interpretation of data need to be addressed. Essential revisions are below:

1\) In order to definitively assess CM proliferation, the authors need to demonstrate increase in CM numbers in addition to staining for markers.

2\) Based on the limited data presented, it is quite an overly strong statement to say that cell rounding is a "prerequisite" for induction of CM cytokinesis. Similarly in the Discussion, it is too strong to say that cytoskeleton and cell cycle are "inseparable" based on the experiments performed.

3\) It doesn\'t appear that the authors measured the compliance of the materials they performed the studies with. This needs to be done to ensure the accuracy of the effects of the reported stiffness (modulus) values. It is not sufficient to rely on previously reported values, and no citation is provided along with the mixture ratios and values provided.

4\) Quantitative methods are generally weak and statistical analyses were not performed correctly. *T*-tests can only be used to compare between two experimental groups. In the case of three or more groups, ANOVA followed by appropriate post-hoc tests must be performed to determine statistical significance. In several cases, no indication of statistical significance is denoted in the figures, yet the authors still make statements comparing results based on absolute values. The authors fail to denote the "n" number of cells throughout most of the manuscript for their various experiments. This critical detail should be provided consistently throughout to ensure all of the results are based on sufficient numbers of cell events. Some of the results appear to be based on a very small number of cells -- [Figure 2H](#fig2){ref-type="fig"} has fewer than ten events for each group.

5\) An alternative mechanism for more proliferation on intermediate softness matrices is that cells are more upright and rounded (like in division) rather than spread as on rigid substrate, but in this case the cell shape on 20kPa needs quantitation (add to [Figures 1C and D](#fig1){ref-type="fig"}). In addition, cell division should be studied on micropatterned substrates.

6\) Since the highly proliferative cardiac fibroblasts and the "non-dividing" cardiomyocytes might share a common progenitor, the authors should prove the specificity of their αMHC driven expression of tdTomato (or is the expression leaky?). In other words, do all tdTomato cells stain for cardiac-specific MHC and/or Troponin? In this respect, [Figures 3E and G](#fig3){ref-type="fig"}, showing more tdTom cells than with cardio markers, should be explained better.

7\) The finding that "rigid matrix promotes karyokinesis without cytokinesis, leading to CM binucleation ([Figure 2G](#fig2){ref-type="fig"})" (in the subsection "Distinct rigidity-dependent cardiomyocyte proliferation mechanisms") seems consistent with results for megakaryocytes cultured on stiff rather than soft gels with high collagen ([@bib40]), but this latter paper used the myosin-II inhibitor blebbistatin as well as collagen density (for cell spreading control) to elucidate some aspects of mechanism. The observations in the present submission by Yahalom-Ronen et al. could benefit from similar (or other) approaches to clarifying some aspect of mechanism.
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Author response

The reviewers were generally favorable about the importance of the study and the conclusions. However, there were several issues that tempered enthusiasm and aspects of the data that did not fully support the conclusions. In particular, issues around the cell types, the rigor with which quantitative analysis is performed, and over interpretation of data need to be addressed. Essential revisions are below.

We sincerely thank the reviewers for their thoughtful comments and suggestions. In the current version of the manuscript, we revised the statistical analyses. Specifically, we conducted ANOVA followed by definitive Post-Hoc tests, both of which yield significant P-values. Importantly, we added new experimental data, addressing: 1) the number of cardiomyocytes (CMs); 2) the effect of actomyosin relaxation (by adding blebbistatin) on CM myoskeleton architecture and proliferation; 3) the influence of the compliant 20kPa substrate on the behavior of the rat neonatal CMs; and 4) the lack of "leakiness" of αMHC-Cre-driven tdTomato fluorescent protein expression in CMs. Finally, we revisited some of our earlier statements, as suggested by the reviewers, and modified them, where necessary.

*1) In order to definitively assess CM proliferation, the authors need to demonstrate increase in CM numbers in addition to staining for markers*.

To directly address the reviewers' comment, we performed a large-scale live-cell imaging analysis of CMs cultured on PDMS displaying the various rigidities. We then traced and quantified CM cytokinesis events that resulted in two daughter CMs. To do so, we performed 6 independent time-lapse experiments. For each experiment, we cultured CMs derived from P1 transgenic *αMHC-Cre;tdTomato-lox* mice on 2 MPa, 20kPa, and 5kPa. After 4 days, we performed time-lapse imaging of the CMs for 48 hours, with 10 min intervals between images. For all rigidities in each experiment, we imaged between 15-30 fields, ranging from 300 to over 700 cells, for a total of 2,878 CMs. In these experiments we counted the number of new CMs and calculated their percentage formed on the two compliant surfaces compared to cells growing on the rigid 2MPa substrate. The results of this analysis appear in new [Figure 2H](#fig2){ref-type="fig"}.

To further quantify the actual increase in CM number, we used the *R26R-Confetti* reporter line, and counted *αMHC-Cre;Confetti-lox* -derived CMs growing on 2MPa, 20kPa, and 5kPa surfaces, between days 4 -11 in culture (over 5,000 CMs). Part of the analysis of the clonal expansion was included in the original submission ([Figure 4H, I](#fig4){ref-type="fig"}). In light of reviewer's comment regarding total CM numbers, formed on the different surfaces, we have now calculated the addition of CMs between days 4 and 7 following cell seeding. This new analysis indicates a significant increase in CM number on the 20kPa and 5kPa substrates (2.4- and ∼1.4-fold, respectively), compared to the "rigid" 2MPa substrate ([Figure 4G, a](#fig4){ref-type="fig"} new panel). These values are in agreement with the increase in proliferation markers, counting of cytokinesis events, and clonal expansion of CMs cultured on the soft matrices.

*2) Based on the limited data presented, it is quite an overly strong statement to say that cell rounding is a "prerequisite" for induction of CM cytokinesis. Similarly in the Discussion, it is too strong to say that cytoskeleton and cell cycle are "inseparable" based on the experiments performed*.

We rephrased the relevant sections in the Results and Discussion sections, indicating that our findings are in line with the view that cell rounding and the decrease in myoskeleton organization correlate well with increased cytokinesis, and refrain from strong causal claims that go beyond the currently available evidence.

*3) It doesn\'t appear that the authors measured the compliance of the materials they performed the studies with. This needs to be done to ensure the accuracy of the effects of the reported stiffness (modulus) values. It is not sufficient to rely on previously reported values, and no citation is provided along with the mixture ratios and values provided*.

The compliance of the PDMS substrates was verified, using a methodology previously employed by [@bib38] conducted in our (the Geiger) lab. Briefly, polymerized slabs of PDMS were subjected to bulk measurements of Young's moduli, using an Instron Universal Testing System. The elastomers prepared for this study had curing agent ratios of 1:10, 1:50 and 1:75, corresponding to Young's moduli of 2MPa, 20kPa and 5kPa, respectively. Specific batches of Sylgard^®^ 184 (Dow Corning), including those used in this study, are routinely tested in our lab. This information was added to the Methods section.

*4) Quantitative methods are generally weak and statistical analyses were not performed correctly.* T*-tests can only be used to compare between two experimental groups. In the case of three or more groups, ANOVA followed by appropriate post-hoc tests must be performed to determine statistical significance. In several cases, no indication of statistical significance is denoted in the figures, yet the authors still make statements comparing results based on absolute values. The authors fail to denote the "n" number of cells throughout most of the manuscript for their various experiments. This critical detail should be provided consistently throughout to ensure all of the results are based on sufficient numbers of cell events. Some of the results appear to be based on a very small number of cells --* [*Figure 2H*](#fig2){ref-type="fig"} *has fewer than ten events for each group*.

In the revised manuscript, statistical significance was determined using ANOVA followed by post-hoc Tukey's (HSD) tests. We further improved the overall validity of the analyzed data by increasing the number of biological repeats in several experiments, and providing the statistical parameters both within the figures themselves, and in the relevant text. We also added the number of cells examined in each experiment throughout the manuscript. Notably, our findings were based on hundreds to thousands of CMs analyzed per experiment. The quantifications of karyokinesis, cytokinesis, and binucleation events described in [Figure 2](#fig2){ref-type="fig"} were obtained from 5 independent time-lapse experiments, and based on the tracking of over 2,000 CMs by analyzing thousands of movies.

It is noteworthy that some events, such as definitive cytokinesis of mature, binucleated CMs, were quite rare events, and observed in only a few cases in our movies. The fact that binucleated CMs can undergo cytokinesis and divide is a highly unexpected event, too rare to be subjected to a standard significance test. In these unusual cases, we refer in the text to the number of events, without calculating their statistical significance. We highlight and further discuss these considerations in the revised manuscript. These results are now moved as a new panel in [Figure 2--figure supplement 1E](#fig2s1){ref-type="fig"}.

*5) An alternative mechanism for more proliferation on intermediate softness matrices is that cells are more upright and rounded (like in division) rather than spread as on rigid substrate, but in this case the cell shape on 20kPa needs quantitation (add to* [*Figures 1C and D*](#fig1){ref-type="fig"}*). In addition, cell division should be studied on micropatterned substrates*.

As requested, we performed additional experiments with compliant substrates on rat neonatal CMs. In [Figures 1C and D](#fig1){ref-type="fig"}, we now provide further quantifications and statistics of CM axial ratio ("polarization") and projected area ("spreading") on 2MPa, 20kPa, and 5kPa substrates. We found that CMs cultured on 20kPa are less polarized than those on 2MPa, but more polarized than those on 5kPa substrates. We observe that CMs on the 20kPa are less spread and more rounded, compared to those cultured on the rigid substrate. However, CMs growing on the 5kPa substrate, although smaller and more rounded than the CMs growing on the 20kPa surfaces, were less proliferative than the CMs cultured on the 20kPa substrate. We cannot yet definitively explain the apparent differences between the rounding and cytoskeletal effects induced by the 5kPa and the 20kPa surfaces, and the effects of the two surfaces on cytokinesis. It is possible that the 5kPa substrate is simply "too soft" for CMs, and cannot support the formation of the actomyosin-based contractile ring, essential for successful cytokinesis. We refer to this issue in the revised text.

The reviewers' suggestion to study cell division on micropatterned substrates is interesting, but we think that it would exceed, by far, the current scope of this research, which focuses on the effects of matrix rigidity on CM cell fates.

*6) Since the highly proliferative cardiac fibroblasts and the "non-dividing" cardiomyocytes might share a common progenitor, the authors should prove the specificity of their αMHC driven expression of tdTomato (or is the expression leaky?). In other words, do all tdTomato cells stain for cardiac-specific MHC and/or Troponin? In this respect,* [*Figures 3E and G*](#fig3){ref-type="fig"}*, showing more tdTom cells than with cardio markers, should be explained better*.

The αMHC-Cre-driven expression of tdTomato is very commonly used in the cardiac regeneration field to label the CM lineage. That said, we now provide further evidence that αMHC-Cre-driven tdTomato expression is not leaky, and is restricted to CMs.

First, we co-stained αMHC-Cre dTomato cells with anti-cTnT antibody. The staining showed an overlap of 99.62% of dTomato^+^/cTnT^+^ CMs, with less than 1% of the dTomato CMs negative for cTnT ([Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}). Secondly, Nkx2.5 is a well-known cardiac marker that identifies embryonic and mature CMs, as well as cardiac progenitors. We therefore co-stained dTomato CMs with Nkx2.5, and found that all dTomato CMs were also positive for Nkx2.5 ([Figure 3H](#fig3){ref-type="fig"}). Taken together, these results strongly demonstrate the "clean" genetic lineage marker system that we used for labeling CMs.

The definition of CM "terminal differentiation" is quite elusive ([@bib49]). CM differentiation is often characterized by binucleation, hypertrophic growth potential, withdrawal from the cell cycle, and increased myofibrillar organization ([@bib49]). Dedifferentiation is often defined as a functional and morphological regression of a mature cell within its own lineage ([@bib21]). Moreover, in both zebrafish and mouse models, dedifferentiation was defined by a partial and transient disassembly of the sarcomeric structure ([@bib22]; [@bib35]).

As explained above, "dTomato" cells represent CMs that express, or have previously expressed, the αMHC gene, a signature of CM differentiation. Under regular conditions, we detected almost 100% of dTomato^+^/cTnT+ CMs. Therefore, dTomato-positive CMs, which were cTnT^-^ or MHC^-^ (protein), reflect the loss of sarcomeric markers within the CM lineage, which is consistent with the definition of CM dedifferentiation, among other parameters such as cell cycle re-entry. We clarify our explanations of this type of analysis in the revised manuscript.

*7) The finding that "rigid matrix promotes karyokinesis without cytokinesis, leading to CM binucleation (*[*Figure 2G*](#fig2){ref-type="fig"}*)" (in the subsection "Distinct rigidity-dependent cardiomyocyte proliferation mechanisms") seems consistent with results for megakaryocytes cultured on stiff rather than soft gels with high collagen (*[@bib40]*), but this latter paper used the myosin-II inhibitor blebbistatin as well as collagen density (for cell spreading control) to elucidate some aspects of mechanism. The observations in the present submission by Yahalom-Ronen et al. could benefit from similar (or other) approaches to clarifying some aspect of mechanism*.

We appreciate this suggestion to investigate some aspect of the mechanism by using the myosin-II inhibitor blebbistatin, which was previously shown to inhibit actin-myosin interactions in mouse CMs ([@bib12]). Specifically, we explored whether disruption of the highly organized architecture of the CM myoskeleton would induce cell cycle reentry. Towards that end, we used the methodology employed by Shin and colleagues ([@bib40]), by culturing 1-day-old neonatal CMs on substrates of varying rigidities (2MPa, 20kPa, 5kPa), allowing them to adhere to the substrate for 72h, and then treating them with 20µM blebbistatin for 24 hours. We then fixed the cells and immunostained them for cTnT and Ki67. We found that blebbistatin severely disrupts the CM myoskeleton, leading to massive disorganization in the sarcomeric system. Blebbistatin treatment further induced a major shift in CM cell shape, manifested by major flattening, dramatic fragmentation of the sarcomeric arrays, and nearly complete loss of striations (new [Figure 4](#fig4){ref-type="fig"}). Taken together, our results indicate that blebbistatin treatment results in severe disorganization of contractile myofilaments in CMs (new [Figure 4](#fig4){ref-type="fig"}).

Since our findings strongly suggest that disruption of the CM myoskeleton facilitates, or is linked to, CM cell cycle re-entry and overall CM dedifferentiation, we analyzed CM cell cycle activity in the absence or presence of blebbistatin, by quantifying the percentage of Ki67^+^/cTnT^+^ cells (n=25,544). This analysis indicated that blebbistatin-treated CMs display higher cell cycle activity compared with control (untreated CMs) on the 2MPa and 20kPa rigidities ([Figure 4C](#fig4){ref-type="fig"}). Hence, we conclude that relaxation of the myoskelton in CMs by blebbistatin promotes cell cycle re-entry. The lack of blebbistatin effect on the 5kPa substrate is consistent with the "already-relaxed" morphology of CMs cultured on the 5kPa substrate.

We suggest that compliant matrices promote CM proliferation primarily via their effect on the mechanics and organization of the myoskeleton. More broadly, we propose that the rigid matrix enhances the forces imposed on the CMs' actin myoskeleton and this facilitates CM differentiation. In contrast, inhibiting CM sarcomeric organization and function (i.e. contractility) by blebbistatin has the opposite effect of inducing CM dedifferentiation. These results point the way toward additional avenues of investigation, which we plan to pursue in greater detail in a follow-up study.
